ANI Pharmaceuticals director Thoma Jeanne sold 1,000 shares at $71.53 per share. The transaction represented about 3.6% of her prior shareholding and left her with 26,762 shares, giving investors a disclosed measure of the sale relative to her ownership position.
Key Highlights
- Thoma Jeanne’s transaction occurred on Sep 11, 2026.
- Her reported ownership after the transaction was 26,762 shares.
- The sale represented about 3.6% of her prior shares holding.
ANI PHARMACEUTICALS INC. (NASDAQ: ANIP) director Thoma Jeanne sold 1,000 shares at $71.53 per share. Her reported ownership after the sale stood at 26,762 shares.
Sale Measured Against Prior Holding
The transaction represented about 3.6% of Thoma Jeanne’s prior shares holding. The post-sale balance of 26,762 shares provides the corresponding ownership figure after completion.
FAQs
Q: What did Thoma Jeanne sell in ANI Pharmaceuticals?
A: ANI Pharmaceuticals director Thoma Jeanne sold 1,000 shares at $71.53 per share. The transaction occurred on Sep 11, 2026, under transaction code S.
Q: What was the stock impact of the ANI Pharmaceuticals director sale?
A: The article does not report an impact on ANI Pharmaceuticals’ stock from the director’s sale. It states that Thoma Jeanne sold 1,000 shares at $71.53 per share, leaving her with 26,762 shares.
Q: How many ANI Pharmaceuticals shares did Thoma Jeanne own after selling?
A: After selling 1,000 shares of ANI Pharmaceuticals at $71.53 per share, director Thoma Jeanne reported ownership of 26,762 shares following the transaction on Sep 11, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.